Role of the NALP3-inflammasome activation by muramyl dipeptide in vivo

Informazioni relative al progetto

NALP3 AND MDP

ID dell’accordo di sovvenzione: 25592

Progetto chiuso

Data di avvio 1 Agosto 2006

Data di completamento 31 Luglio 2008

Finanziato da

• Human resources and Mobility in the specific programme for research, technological development and demonstration "Structuring the European Research Area" under the Sixth Framework Programme 2002-2006

Costo totale € 0,00

Contributo UE € 183 456,00

Coordinato da

DEPARTEMENT DE BIOCHIMIE, UNIVERSITE DE LAUSANNE
Switzerland

Obiettivo

Innate

Campo scientifico

• natural sciences › biological sciences › genetics › DNA
• natural sciences › chemical sciences › inorganic chemistry › alkali metals
• medical and health sciences › basic medicine › immunology
• natural sciences › biological sciences › genetics › mutation
• natural sciences › biological sciences › biochemistry › biomolecules › proteins › enzymes

Parole chiave

• IL
• NALP3
• adjuvant
• immunity
• in vivo

Programma(i)

• FP6-MOBILITY - Human resources and Mobility in the specific programme for research, technological development and demonstration "Structuring the European Research Area" under the Sixth Framework Programme 2002-2006

Argomento(i)

• MOBILITY-2.1 - Marie Curie Intra-European Fellowships (EIF)

Invito a presentare proposte

FP6-2004-MOBILITY-5
Vedi altri progetti per questo bando

Meccanismo di finanziamento

EIF - Marie Curie actions-Intra-European Fellowships

Coordinatore

DEPARTEMENT DE BIOCHIMIE, UNIVERSITE DE LAUSANNE

• Contributo UE: Nessun dato
• Indirizzo: chemin des boveresses 155 ; EPALINGES ; Svizzera
• Costo totale: Nessun dato